Tag: 上海夜生活FSU

Startup Spotlight: A new way to rally immune cells into action against cancer

first_img STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Startup Spotlight: A new way to rally immune cells into action against cancer By Meghana Keshavan Jan. 4, 2017 Reprints Alex Hogan/STAT Immunotherapy is a delicate balance: You have to rally a patient’s immune cells into action to kill diseased cells, but keep them away from healthy tissues. Vedantra Pharmaceuticals, a startup based in Cambridge, Mass., is working on a way to refine that process.The company has developed next-gen nanoparticle vaccines — engineering vesicles that help ferry the therapy straight to the lymph nodes. That helps the body generate a stronger immune response. The work, based on research at MIT, is still preclinical, but Vedantra hopes it can be used to bolster cancer treatments. It’s focusing first on malignancies provoked by the HPV virus — such as cervical and head and neck cancer. What is it? Log In | Learn More Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+. First 30 days free. GET STARTED About the Author Reprints [email protected] center_img Biotech Correspondent Meghana covers biotech and contributes to The Readout newsletter. GET STARTED @megkesh What’s included? Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. Biotech Meghana Keshavan Tags cancerdrug developmentSTAT+last_img read more